Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation. Part 1. Pharmacokinetic and Pharmacodynamic Aspects

by V.V. Poltorak, N.A. Kravchun, M.Yu. Gorshunska
Published 2015-10-01

Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety

by V.V. Poltorak, N.А. Kravchun, M.Yu. Gorshunska
Published 2015-11-01

Adiponectin and Diabetes Mellitus Type 2 (Pathogenic Aspects as the Ground for Antidiabetic Pharmacotherapy Optimization)

by V.V. Роltorak, M.Yu. Gorshunska, N.S. Krasova
Published 2014-08-01

Amaryl®М SR: a New Release Form, New Possibilities for The Patients

by V.V. Роltorak, M.Yu. Gorshunska, N.S. Krasova
Published 2015-08-01

Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus

by M. Yu. Gorshunska, Y. I. Karachentsev, N. A. Kravchun, E. Jansen3, Zh. A. Leshchenko, A. I. Gladkih, N. S. Krasova, T. V. Tyzhnenko, Y. A. Opaleyko, V. V. Роltorak
Published 2013-06-01